{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-046223","form_type":"8-K","ticker":"AQST","cik":"0001398733","company_name":"Aquestive Therapeutics, Inc.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.343025+00:00","generated_at":"2026-05-30T03:23:56.877371+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Aquestive board member Santo J. Costa resigns; Cochran and Morris assume committee roles","bullets":["Santo J. Costa resigned from board effective Nov 4, 2024 for personal reasons; no disagreement with company.","John S. Cochran appointed Chair of Compensation Committee effective Nov 4, 2024.","Timothy E. Morris added to Compensation Committee; board size reduced from 8 to 7 directors.","Company thanked Costa for his years of service and dedication."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-046223","json":"https://secwatch.observer/filing/0001628280-24-046223.json","markdown":"https://secwatch.observer/filing/0001628280-24-046223.md","text":"https://secwatch.observer/filing/0001628280-24-046223.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1398733/000162828024046223/0001628280-24-046223-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1398733/000162828024046223/aqst-20241101.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:23:56.877371+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a767328166","claim":"Santo J. Costa resigned as Director at Aquestive Therapeutics, Inc..","evidence_excerpt":"On November 1, 2024, Santo J. Costa, a member of the Board of Directors of Aquestive Therapeutics, Inc. (the “Company”) and the Chairman of the Compensation Committee thereof (the “Compensation Committee”), notified the Company of his intention to resign from the Company's Board of Directors for personal reasons, effective November 4, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1398733/000162828024046223/0001628280-24-046223-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}